Boule Diagnostics Future Growth
Future criteria checks 3/6
Boule Diagnostics is forecast to grow earnings and revenue by 35.7% and 6.3% per annum respectively while EPS is expected to grow by 33% per annum.
Key information
35.7%
Earnings growth rate
33.0%
EPS growth rate
Medical Equipment earnings growth | 16.6% |
Revenue growth rate | 6.3% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 08 May 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 658 | 59 | 46 | 92 | 2 |
12/31/2024 | 607 | 50 | 40 | 81 | 2 |
12/31/2023 | 574 | 40 | -11 | 73 | 2 |
3/31/2023 | 559 | 16 | -91 | -19 | N/A |
12/31/2022 | 548 | 13 | -86 | -11 | N/A |
9/30/2022 | 539 | 27 | -88 | -14 | N/A |
6/30/2022 | 525 | 32 | -57 | 12 | N/A |
3/31/2022 | 495 | 28 | -32 | 29 | N/A |
12/31/2021 | 463 | 23 | -13 | 43 | N/A |
9/30/2021 | 416 | -27 | 3 | 57 | N/A |
6/30/2021 | 403 | -13 | 14 | 64 | N/A |
3/31/2021 | 383 | -55 | 25 | 73 | N/A |
12/31/2020 | 400 | -48 | 29 | 75 | N/A |
9/30/2020 | 437 | -8 | 26 | 70 | N/A |
6/30/2020 | 470 | -8 | 29 | 76 | N/A |
3/31/2020 | 499 | 35 | 26 | 73 | N/A |
12/31/2019 | 499 | 38 | 6 | 54 | N/A |
9/30/2019 | 476 | 32 | -14 | 41 | N/A |
6/30/2019 | 456 | 21 | -37 | 16 | N/A |
3/31/2019 | 444 | 36 | -59 | 11 | N/A |
12/31/2018 | 424 | 41 | -42 | 23 | N/A |
9/30/2018 | 425 | 48 | -13 | 40 | N/A |
6/30/2018 | 424 | 60 | 4 | 51 | N/A |
3/31/2018 | 421 | 43 | 26 | 46 | N/A |
12/31/2017 | 428 | 37 | 44 | 58 | N/A |
9/30/2017 | 422 | 31 | 37 | 45 | N/A |
6/30/2017 | 421 | 28 | 32 | 38 | N/A |
3/31/2017 | 419 | 38 | 28 | 32 | N/A |
12/31/2016 | 397 | 36 | N/A | 20 | N/A |
9/30/2016 | 383 | 36 | N/A | 20 | N/A |
6/30/2016 | 364 | 22 | N/A | 28 | N/A |
3/31/2016 | 341 | 15 | N/A | 29 | N/A |
12/31/2015 | 331 | 15 | N/A | 22 | N/A |
9/30/2015 | 333 | 29 | N/A | 22 | N/A |
6/30/2015 | 318 | 33 | N/A | 8 | N/A |
3/31/2015 | 309 | 33 | N/A | 21 | N/A |
12/31/2014 | 307 | 30 | N/A | 31 | N/A |
9/30/2014 | 289 | 14 | N/A | 16 | N/A |
6/30/2014 | 285 | -68 | N/A | 35 | N/A |
3/31/2014 | 287 | -64 | N/A | 23 | N/A |
12/31/2013 | 277 | -70 | N/A | 16 | N/A |
9/30/2013 | 281 | -65 | N/A | 15 | N/A |
6/30/2013 | 275 | 8 | N/A | 7 | N/A |
3/31/2013 | 274 | 7 | N/A | 9 | N/A |
12/31/2012 | 275 | 11 | N/A | 11 | N/A |
9/30/2012 | 267 | 10 | N/A | 29 | N/A |
6/30/2012 | 261 | 12 | N/A | 13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BDAB.F's forecast earnings growth (35.7% per year) is above the savings rate (2.1%).
Earnings vs Market: BDAB.F's earnings (35.7% per year) are forecast to grow faster than the US market (14.9% per year).
High Growth Earnings: BDAB.F's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: BDAB.F's revenue (6.3% per year) is forecast to grow slower than the US market (8.1% per year).
High Growth Revenue: BDAB.F's revenue (6.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BDAB.F's Return on Equity is forecast to be high in 3 years time